FDA Approves the first Mesenchymal Stromal Cell Therapy to Treat the Graft Versus Host Disease in Adults and Children

Mesoblast Biotechnology Company has received FDA approval for its Ryoncil therapy as the first of its kind to be approved in the United States. The therapy has been developed to…

Continue Reading FDA Approves the first Mesenchymal Stromal Cell Therapy to Treat the Graft Versus Host Disease in Adults and Children
Chronic Granulomatous Disease: A Stem Cell Transplant Approach to Speed up the Wait List
source: pixabay.com

Chronic Granulomatous Disease: A Stem Cell Transplant Approach to Speed up the Wait List

  According to Dr. Deepak Chellapandian, a Johns Hopkins specialist in bone marrow transplant for rare diseases, the prognosis for his patient was very poor. Jocelyn was born with chronic…

Continue Reading Chronic Granulomatous Disease: A Stem Cell Transplant Approach to Speed up the Wait List